In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on ...

The Catharanthine market, primarily recognized for its role in the production of anti-cancer drugs like vinblastine and vincristine, has long been examined through the lens of oncology. However, ...

Flowers grow stems, leaves and petals in a perfect pattern again and again. A new Cornell study shows that even in this ...

When you see large language models passing medical licensing exams, it’s easy to wonder—how long until AI becomes the doctor?

A multi-institutional collaboration of synthetic biology research centers in China has developed a genetically engineered ...

Synthetic biology is reshaping how we approach therapeutics. Using engineering principles in biology, it is possible to “rewire” cells by reconstructing the underlying biological code to create new ...

Molecular Devices, LLC., a leading high-performance life science solutions provider, today launched the QPix® FLEX™ Microbial Colony Picking System. Building on the company's 20-year legacy developing ...

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm's Tanja Dowe.

Synthetic biology is the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes. Five gene clusters ...

Yorgo El Moubayed is a program coordinator at the iGEM Foundation, running the world’s biggest synthetic biology competition.

The Howard P. Isermann Department of Chemical and Biological Engineering, in partnership with the School of Engineering at Rensselaer Polytechnic Institute (RPI), is proud to announce Mattheos Koffas, ...